FLT3 Mutation Analysis-FLT3-ITD

Unique Identifier:

ML-H001


Name on Requisition:

FLT3-ITD


Product Line:

HEME


Panel Group:

PCR


Panel Name:

FLT3-ITD & TKD by PCR


Methodology

Molecular
PCR


Test Description and clinical significance

Genes
FLT3 (ITD variants , exon14,15)

Disease:
acute myeloid leukemia

A polymerase chain reaction test aiming for detection of mutations in the FLT3 gene which are common mutations in acute myeloid leukemia (AML). This assay detects internal tandem duplication (ITD) mutations and mutations in the tyrosine kinase domain (TKD) of FLT3. Presence of these mutations in AML provide prognostic information and can aid in the determination of therapeutic regimen.


Specimen Requirements

Preparation:
PB, BM

Collection:
at least 0.5 mL EDTA, citrate (ACD) or Heparinized bone marrow and peripheral blood specimens

Stability:
96hours/4 to 7 days refrigerated

Unacceptable Conditions:
Specimen submitted is in the incorrect fixative or anticoagulant. Specimen received after the stability date. Gross hemolysis. Frozen specimen. Insufficient specimen. Unlabeled


Storage & Transport

Blood or bone marrow specimens should be kept at room temperature and preferably received within 96 hours of drawing. Samples that are 4 to 7 days old should be refrigerated.


CPT(s)

81245


TAT

3


Requisition Type

Heme


Levels of Service

Full


DexS Code

Z00XQ


Prefix

MI


*The CPT codes provided are for informational purposes only and are based on AMA guidelines The billing party is solely responsible for correct CPT coding.

Discover more.

A Model Experience

With core values rooted in service and integrity, our leadership team sets the bar high.

We consistently strive to set the model for exactly how a reference laboratory should engage with both physicians and patients.

Accredited and Certified

siParadigm is accredited by CLIA (Clinical Laboratory Improvement Amendments) and certified by CAP (College of American Pathologists).

We also hold select state licensure where required.